Optometry News

Healio’s top video perspectives from the American Society of Retina Specialists meeting highlight faricimab in diabetic macular edema as well as an axitinib implant for wet age-related macular degeneration.

In this Healio Video Perspective from the ASRS meeting, Jordana G. Fein, MD, MS, of Retina Group of Washington discusses IOP outcomes in patients with diabetic macular edema who were treated with aflibercept 8 mg or aflibercept 2 mg.

Eighteen medications appeared to be associated with angle-closure glaucoma, including sulfonamides, serotonergic agents and antimuscarinic agents, according to a retrospective analysis published in Ophthalmology Glaucoma.

HCP Cureblindness is rebranding as the Cure Blindness Project, according to a press release.

Many patients with ocular surface disease have sought relief at their hometown pharmacies with long-proven, branded lubricants.

Healio’s articles from the American Society of Retina Specialists meeting have covered long-term improvements with Luxturna and macular hole closure rates with different pars plana vitrectomy techniques.

Optometry in the 21st century has moved strongly toward evidence-based medicine, with the American Optometric Association even publishing a 14-step process to assist in the development of an evidence-based practice.

The latest Vision Council Consumer inSights report highlights key generational differences in eye care, with younger generations less likely to receive their next exam within 12 months, despite an increase in vision coverage.

Despite advances in head-mounted displays, patients are often dissatisfied with their performance, according to a study published in Ophthalmic and Physiological Optics.

Sozinibercept, a VEGF-C and -D “trap” inhibitor, showed improved durability in patients with retinal diseases when delivered as a combination therapy vs. anti-VEGF-A monotherapies, according to a study.